183 related articles for article (PubMed ID: 9795212)
1. MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions.
Roy S; Barke RA; Loh HH
Brain Res Mol Brain Res; 1998 Oct; 61(1-2):190-4. PubMed ID: 9795212
[TBL] [Abstract][Full Text] [Related]
2. mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit.
Roy S; Liu HC; Loh HH
Brain Res Mol Brain Res; 1998 May; 56(1-2):281-3. PubMed ID: 9602153
[TBL] [Abstract][Full Text] [Related]
3. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
4. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor.
Wang J; Charboneau R; Balasubramanian S; Barke RA; Loh HH; Roy S
J Leukoc Biol; 2002 May; 71(5):782-90. PubMed ID: 11994502
[TBL] [Abstract][Full Text] [Related]
5. Nerve injury induces a tonic bilateral mu-opioid receptor-mediated inhibitory effect on mechanical allodynia in mice.
Mansikka H; Zhao C; Sheth RN; Sora I; Uhl G; Raja SN
Anesthesiology; 2004 Apr; 100(4):912-21. PubMed ID: 15087627
[TBL] [Abstract][Full Text] [Related]
6. Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
Gavériaux-Ruff C; Matthes HW; Peluso J; Kieffer BL
Proc Natl Acad Sci U S A; 1998 May; 95(11):6326-30. PubMed ID: 9600964
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
[TBL] [Abstract][Full Text] [Related]
8. Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Franchi S; Moretti S; Castelli M; Lattuada D; Scavullo C; Panerai AE; Sacerdote P
Brain Behav Immun; 2012 Mar; 26(3):480-8. PubMed ID: 22240038
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of morphine, DPDPE, and U-50488 on apomorphine-induced climbing behavior in mu-opioid receptor knockout mice.
Jang CG; Lee SY; Park Y; Ma T; Loh HH; Ho IK
Brain Res Mol Brain Res; 2001 Oct; 94(1-2):197-9. PubMed ID: 11597780
[TBL] [Abstract][Full Text] [Related]
10. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
11. Involvement of mu- and delta-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress.
Matsuzawa S; Suzuki T; Misawa M; Nagase H
Brain Res; 1998 Aug; 803(1-2):169-77. PubMed ID: 9729364
[TBL] [Abstract][Full Text] [Related]
12. Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice.
Hough LB; Nalwalk JW; Chen Y; Schuller A; Zhu Y; Zhang J; Menge WM; Leurs R; Timmerman H; Pintar JE
Brain Res; 2000 Oct; 880(1-2):102-8. PubMed ID: 11032994
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
14. Visceral chemical nociception in mice lacking mu-opioid receptors: effects of morphine, SNC80 and U-50,488.
Sora I; Li XF; Funada M; Kinsey S; Uhl GR
Eur J Pharmacol; 1999 Feb; 366(2-3):R3-5. PubMed ID: 10082217
[TBL] [Abstract][Full Text] [Related]
15. Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice.
Roy S; Wang JH; Balasubramanian S; Sumandeep ; Charboneau R; Barke R; Loh HH
J Neuroimmunol; 2001 Jun; 116(2):147-55. PubMed ID: 11438169
[TBL] [Abstract][Full Text] [Related]
16. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
Matsuzawa S; Suzuki T; Misawa M; Nagase H
Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
[TBL] [Abstract][Full Text] [Related]
17. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
[TBL] [Abstract][Full Text] [Related]
18. Expression of functional mu-opioid receptors during T cell development.
McCarthy L; Szabo I; Nitsche JF; Pintar JE; Rogers TJ
J Neuroimmunol; 2001 Mar; 114(1-2):173-80. PubMed ID: 11240029
[TBL] [Abstract][Full Text] [Related]
19. Morphine-induced place preference in the CXBK mouse: characteristics of mu opioid receptor subtypes.
Suzuki T; Funada M; Narita M; Misawa M; Nagase H
Brain Res; 1993 Jan; 602(1):45-52. PubMed ID: 8383571
[TBL] [Abstract][Full Text] [Related]
20. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
